Circulating oxidized low-density lipoproteins and arterial elasticity: Comparison between men with metabolic syndrome and physically active counterparts

Cardiovascular Diabetology

Volumn 9, Issue , 2010, Pages

  Pohjantähti Maaroos, Hanna ^a,b,c   Palomäki, Ari ^a,b   Kankkunen, Päivi ^a   Laitinen, Ruth ^b   Husgafvel, Sari ^a   Oksanen, Kalevi ^a  

^a KANTA HÄME CENTRAL HOSPITAL   (Finland)

^b Linnan Klinikka   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ARTERY ELASTICITY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED STUDY; ELASTICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INVASIVE PROCEDURE; PHYSICAL ACTIVITY; TONOMETRY; ADULT; ARTERY; ATHEROSCLEROSIS; BLOOD; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CROSS-SECTIONAL STUDY; FINLAND; LIFESTYLE; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; VASCULAR ENDOTHELIUM;

ADULT; ARTERIES; ATHEROSCLEROSIS; CROSS-SECTIONAL STUDIES; ELASTICITY; ENDOTHELIUM, VASCULAR; FINLAND; HUMANS; LIFE STYLE; LIPOPROTEINS, LDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOTOR ACTIVITY; RISK FACTORS;

EID: 77955669150     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-9-41     Document Type: Article

References (50)

1. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly D, Haffner S, Isles C, Macfarlane P, Packard C, Shepherd J. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland coronary prevention study. Circulation 2003, 108:414-419. 10.1161/01.CIR.0000080897.52664.94, 12860911.
2. Lakka H-M, Laaksonen D, Lakka T, Niskanen L, Kumpusalo E, Tuomilehto J, Salonen J. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2716. 10.1001/jama.288.21.2709, 12460094.
3. Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989, 320:915-924. 10.1056/NEJM198901053200122, 2648148.
4. Hulthe J, Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (Air Study). Arterioscler Thromb Vasc Biol 2002, 22:1162-1167. 10.1161/01.ATV.0000021150.63480.CD, 12117732.
5. Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W. Plasma oxidized low- density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 2005, 112:651-657. 10.1161/CIRCULATIONAHA.104.529297, 16043640.
6. Cohn J. Vascular wall function as a risk marker for cardiovascular disease. J Hypertens 1999, 17:41-44.
7. Boutouyrie P, Tropeano I, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients. A longitudinal study. Hypertension 2002, 39:10-15. 10.1161/hy0102.099031, 11799071.
8. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects > 70 years of age. Arterioscler Thromb Vasc Biol 2001, 21:2046-2050. 10.1161/hq1201.100226, 11742883.
9. Cohn J, Finkelstein S, McVeigh G, Morgan D, LeMay L, Robinson J, Mock J. Non-invasive pulse wave analysis for the early detection of vascular disease. Hypertension 1995, 26:503-508.
10. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Final report. Circulation 2002, 106:3143-3421.
11. Aittasalo M, Miilunpalo S, Suni J. The effectiveness of physical activity counselling in a work-site setting. A randomized controlled trial. Patient Educ Couns 2004, 55:193-202. 10.1016/j.pec.2003.09.003, 15530754.
12. Ainsworth B, Haskell W, Whitt M, Irwin M, Swartz A, Strath S, O'Brien W, Basset D, Schmitz K, Emplaincourt P, Jacobs D, Leon A. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000, 32:498-516.
13. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ, . A1c-Derived Average Glucose Study Group Translating the A1C assay into estimated average glucose values. Diabetes Care 2008, 31:1473-1478. 10.2337/dc08-0545, 2742903, 18540046, A1c-Derived Average Glucose Study Group.
14. Pai J, Curhan C, Cannuscio C, Rifai N, Ridker P, Rimm E. Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection. Clin Chem 2002, 48:1781-1784.
15. Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R, Collen D, Muls E, Van de Werf F. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001, 21:844-848. 10.1161/hq1201.100221, 11348884.
16. Valle Gottlieb M, da Gruz I, Duarte M, Moresco R, Wiehe M, Schwanke C, Bodanese L. Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers. J Clin Endocrinol Metab 2010, 95:586-591. 10.1210/jc.2009-1592, 20016051.
17. Ueba T, Nomura S, Nishikawa T, Kajiwara M, Yamashita K. Circulating oxidized LDL, measured with FOH1a/DLH3 antibody, is associated with metabolic syndrome and the coronary heart disease risk score in healthy Japanese. Atherosclerosis 2009, 203:243-248. 10.1016/j.atherosclerosis.2008.05.048, 18635189.
18. Lapointe A, Couillard C, Piche M-E, Weisnagel S, Bergeron J, Nadeau A, Lemieux S. Circulating oxidized LDL is associated with parameters of the metabolic syndrome in postmenopausal women. Atherosclerosis 2007, 191:362-368. 10.1016/j.atherosclerosis.2006.03.036, 16677652.
19. Holvoet P, Kritchevsky S, Tracy R, Mertens A, Rubin S, Butler J, Goodpaster B, Harris T. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 2004, 53:1068-1073. 10.2337/diabetes.53.4.1068, 15047623.
20. Sigurdardottir V, Fagerberg B, Hulthe J. Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). J Intern Med 2002, 252:440-447. 10.1046/j.1365-2796.2002.01054.x, 12528762.
21. Sjogren P, Basu S, Rosell M, Silveira A, de Faire U, Vessby B, Hamsten A, Hellenius M-L, Fisher R. Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome. Arterioscler Thromb Vasc Biol 2005, 25:2580-2586. 10.1161/01.ATV.0000190675.08857.3d, 16224051.
22. Talmud PJ, Stphens JW, Hawe E, Demissie S, Cupples LA, Hurel SJ, Humphries SE, Ordovas JM. The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann Hum Genet 2005, 69:613-622. 10.1111/j.1529-8817.2005.00205.x, 16266401.
23. Schroder H, Marrugat J, Fito M, Weinbrenner T, Covas MI. Alcohol consumption is directly associated with circulating oxidized low-density lipoprotein. Free Radic Biol Med 2006, 40:1474-1481. 10.1016/j.freeradbiomed.2005.12.014, 16631537.
24. Ziegler S, Schaller G, Mittermayer F, Pleiner J, Mihaly J, Niessner A, Richter B, Steiner- Boeker S, Penak M, Strasser B, Wolz M. Exercise training improves low-density lipoprotein oxidability in untrained subjects with coronary artery disease. Arch Phys Med Rehabil 2006, 87:265-269. 10.1016/j.apmr.2005.09.025, 16442983.
25. Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman M, Kontush A. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004, 89:4963-4971. 10.1210/jc.2004-0305, 15472192.
26. Madamanchi N, Vendrov A, Runge M. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005, 25:29-38. 10.1161/01.ATV.0000161050.77646.68, 15539615.
27. Sarigianni M, Bekiari E, Tsapas A, Topouridou K, Kaloyianni M, Koliakos G, Paletas K. Effect of glucose and insulin on oxidized low-density lipoprotein phagocytosis by human monocytes: a pilot study. Angiology 2010,
28. Lamarche B. Abdominal obesity and its metabolic complications: implications for the risk of ischaemic heart disease. Coron Artery Dis 1998, 9:473-481. 10.1097/00019501-199809080-00002, 9847978.
29. Tentolouris N, Papazafiropoulou A, Moyssakis I, Liatis S, Perrea D, Kostakis M, Katsilambros N. Metabolic syndrome is not associated with reduction in aortic distensibility in subjects with type 2 diabetes mellitus. Cardiovasc Diabetol 2008, 7:1. 10.1186/1475-2840-7-1, 2235836, 18171473.
30. Woodman R, Kingwell B, Beilin L, Hamilton S, Dart A, Watts G. Assessment of central and peripheral arterial stiffness. Studies indicating the need to use a combination of techniques. Am J Hypertens 2005, 18:249-260. 10.1016/j.amjhyper.2004.08.038, 15752954.
31. Van Bortel L, Duprez D, Starmans-Kool M, Safar M, Giannattasio C, Cockroft J, Kaiser D, Thuillez C. Applications of arterial stiffness, Task Force III: recommendations for user procedures. Am J Hypertens 2002, 15:445-452. 10.1016/S0895-7061(01)02326-3, 12022247.
32. Ge JY, Li XL, Zhang HF, Xu Q, Tong M, Wang JG. Elasticity indices of large and small arteries in relation to the metabolic syndrome in Chinese. Am J Hypertens 2008, 21:143-147. 10.1038/ajh.2007.26, 18188165.
33. Fjeldstad A, Fjeldstad C, Acree L, Nickel K, Montgomery P, Comp P, Whitsett T, Gardner A. The relationship between arterial elasticity and metabolic syndrome features. Angiology 2007, 58:5-10. 10.1177/0003319706297911, 17351152.
34. Kals J, Kampus P, Kals M, Zilmer K, Kullisaar T, Teesalu R, Pulges A, Zilmer M. Impact of oxidative stress on arterial elasticity in patients with atherosclerosis. Am J Hypertens 2006, 19:902-908. 10.1016/j.amjhyper.2006.02.003, 16942931.
35. Morishita R, Ishii J, Kusumi Y, Yamada S, Komai N, Ohishi M, Nomura M, Hishida H, Niihashi M, Mitsumata M. Association of serum oxidized lipoprotein(a) concentration with coronary artery disease: potential role of oxidized lipoprotein(a) in the vascular wall. J Atheroscler Thromb 2009, 16:410-418.
36. Moreau K, Gavin K, Plum A, Seals D. Oxidative stress explains differences in large artery elastic compliance between sedentary and habitually exercising postmenopausal women. Menopause 2006, 13:951-958. 10.1097/01.gme.0000243575.09065.48, 16977254.
37. Toikka J, Niemi P, Ahotupa M, Niinikoski H, Viikari J, Rönnemaa T, Hartiala J, Raitakari O. Large-artery elastic properties in young men. Relationships to serum lipoproteins and oxidized low-density lipoproteins. Arterioscler Thromb Vasc Biol 1999, 19:436-441.
38. Escobedo J, Schargrodsky H, Champagne B, Silva H, Boissonnet C, Vinueza R, Torres M, Hernandez R, Wilson E. Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol 2009, 8:52. 10.1186/1475-2840-8-52, 2760519, 19781089.
39. Glasser S, Arnett D, McVeigh G, Finkelstein S, Bank A, Morgan D, Cohn J. Vascular compliance and cardiovascular disease. A risk factor or a marker?. Am J Hypertens 1997, 10:1175-1189. 10.1016/S0895-7061(97)00311-7, 9370391.
40. Van Popele N, Grobbee D, Bots M, Asmar R, Topouchian J, Reneman R, Hoeks A, Van der Kuip D, Hofman A, Witteman J. Association between arterial stiffness and atherosclerosis. The Rotterdam study. Stroke 2001, 32:454-460.
41. Sugawara J, Inoue H, Haysashi K, Yokoi T, Kono I. Effect of low-intensity aerobic exercise training on arterial compliance in postmenopausal women. Hypertens Res 2004, 27:897-901. 10.1291/hypres.27.897, 15894828.
42. Miyachi M, Donato A, Yamamoto K, Takahashi K, Gates P, Moreau K, Tanaka H. Greater age-related reductions in central arterial compliance in resistance trained men. Hypertension 2003, 41:130-135. 10.1161/01.HYP.0000047649.62181.88, 12511542.
43. Miyachi M, Kawano H, Sugawara J, Takahashi K, Hayashi K, Yamazaki K, Tabata I, Tanaka H. Unfavorable effects of resistance training on central arterial compliance. A randomized intervention study. Circulation 2004, 110:2858-2863. 10.1161/01.CIR.0000146380.08401.99, 15492301.
44. Perkins G, Owen A, Swaine L, Wiles J. Relationships between pulse wave velocity and heart rate variability in healthy men with a range of moderate to vigorous physical activity levels. Eur J Appl Physiol 2006, 98:516-523. 10.1007/s00421-006-0303-9, 17013591.
45. Plantinga Y, Ghiadoni L, Magagna A, Giannarelli C, Penno G, Pucci L, Taddei S, Del Prato S, Salvetti A. Peripheral wave reflection and endothelial function in untreated essential hypertensive patients with and without metabolic syndrome. J Hypertens 2008, 26:1216-1222. 10.1097/HJH.0b013e3282fa7158, 18475160.
46. McVeigh G, Brennan G, Hayes R, Cohn J, Finkelstein S, Johnston D. Vascular abnormalities in non-insulin dependent diabetes mellitus identified by arterial waveform analysis. Am J Med 1993, 95:424-430. 10.1016/0002-9343(93)90313-E, 8213876.
47. McVeigh G, Burns D, Finkelstein S, McDonald K, Mock J, Feske W, Carlyle P, Flack J, Grimm R, Cohn J. Reduced vascular compliance as a marker for essential hypertension. Am J Hypertens 1991, 4:245-251.
48. Leibovitz E, Hazanov N, Zimlichman R, Shargorodsky M, Gavish D. Treatment with atorvastatin improves small artery compliance in patients with severe hypercholesterolemia. Am J Hypertens 2001, 14:1096-1098. 10.1016/S0895-7061(01)02210-5, 11724206.
49. Cohn J. ACE inhibition and vascular remodeling of resistance vessels. Vascular compliance and cardiovascular implications. Heart Dis 2000, 2:52-56.
50. Nashar K, Nguyen J, Jesri A, Morrow J, Egan B. Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome. Am J Hypertens 2004, 17:477-482. 10.1016/j.amjhyper.2004.02.015, 15177518.